These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9378841)
21. Effects of caffeine on performance and mood depend on the level of caffeine abstinence. Yeomans MR; Ripley T; Davies LH; Rusted JM; Rogers PJ Psychopharmacology (Berl); 2002 Nov; 164(3):241-9. PubMed ID: 12424547 [TBL] [Abstract][Full Text] [Related]
22. Caffeine effects on recovery sleep following 27 h total sleep deprivation. LaJambe CM; Kamimori GH; Belenky G; Balkin TJ Aviat Space Environ Med; 2005 Feb; 76(2):108-13. PubMed ID: 15742825 [TBL] [Abstract][Full Text] [Related]
23. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131 [TBL] [Abstract][Full Text] [Related]
24. Dissociations between motor timing, motor coordination, and time perception after the administration of alcohol or caffeine. Terry P; Doumas M; Desai RI; Wing AM Psychopharmacology (Berl); 2009 Mar; 202(4):719-29. PubMed ID: 18846366 [TBL] [Abstract][Full Text] [Related]
25. Behavioral effects of caffeine and other methylxanthines on children. Hughes JR; Hale KL Exp Clin Psychopharmacol; 1998 Feb; 6(1):87-95. PubMed ID: 9526149 [TBL] [Abstract][Full Text] [Related]
26. Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Landolt HP; Rétey JV; Tönz K; Gottselig JM; Khatami R; Buckelmüller I; Achermann P Neuropsychopharmacology; 2004 Oct; 29(10):1933-9. PubMed ID: 15257305 [TBL] [Abstract][Full Text] [Related]
27. Risk-taking behavior: effects of ethanol, caffeine, and basal sleepiness. Roehrs T; Greenwald M; Roth T Sleep; 2004 Aug; 27(5):887-93. PubMed ID: 15453546 [TBL] [Abstract][Full Text] [Related]
28. Caffeine and theophylline counteract diazepam effects in man. Mattila MJ; Nuotto E Med Biol; 1983; 61(6):337-43. PubMed ID: 6374311 [TBL] [Abstract][Full Text] [Related]
29. Quadratic dose-response relationship between caffeine (1,3,7-trimethylxanthine) and EEG correlation dimension. Watters PA; Martin F; Schreter Z Psychopharmacology (Berl); 1998 Apr; 136(3):264-71. PubMed ID: 9566812 [TBL] [Abstract][Full Text] [Related]
31. The effects of low doses of caffeine on human performance and mood. Lieberman HR; Wurtman RJ; Emde GG; Roberts C; Coviella IL Psychopharmacology (Berl); 1987; 92(3):308-12. PubMed ID: 3114783 [TBL] [Abstract][Full Text] [Related]
32. A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and mood. Dodd FL; Kennedy DO; Riby LM; Haskell-Ramsay CF Psychopharmacology (Berl); 2015 Jul; 232(14):2563-76. PubMed ID: 25761837 [TBL] [Abstract][Full Text] [Related]
33. Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance. Rogers PJ; Heatherley SV; Mullings EL; Smith JE Psychopharmacology (Berl); 2013 Mar; 226(2):229-40. PubMed ID: 23108937 [TBL] [Abstract][Full Text] [Related]
35. Caffeine expectancies influence the subjective and behavioral effects of caffeine. Harrell PT; Juliano LM Psychopharmacology (Berl); 2009 Dec; 207(2):335-42. PubMed ID: 19760283 [TBL] [Abstract][Full Text] [Related]
36. Effect of caffeine and taurine on simulated laparoscopy performed following sleep deprivation. Aggarwal R; Mishra A; Crochet P; Sirimanna P; Darzi A Br J Surg; 2011 Nov; 98(11):1666-72. PubMed ID: 21761394 [TBL] [Abstract][Full Text] [Related]
37. Creatine and caffeine in anaerobic and aerobic exercise: effects on physical performance and pharmacokinetic considerations. Vanakoski J; Kosunen V; Meririnne E; Seppälä T Int J Clin Pharmacol Ther; 1998 May; 36(5):258-62. PubMed ID: 9629989 [TBL] [Abstract][Full Text] [Related]
38. Effects of caffeine on the electrophysiological, cognitive and motor responses of the central nervous system. Deslandes AC; Veiga H; Cagy M; Piedade R; Pompeu F; Ribeiro P Braz J Med Biol Res; 2005 Jul; 38(7):1077-86. PubMed ID: 16007279 [TBL] [Abstract][Full Text] [Related]
39. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423 [TBL] [Abstract][Full Text] [Related]
40. Caffeine as an attention enhancer: reviewing existing assumptions. Einöther SJ; Giesbrecht T Psychopharmacology (Berl); 2013 Jan; 225(2):251-74. PubMed ID: 23241646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]